Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: January 12, 2026
18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.
Journal: Journal of substance use and addiction treatment
Published: December 14, 2022
Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings.
Journal: Journal of addiction medicine
Published: September 16, 2022
Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection.
Journal: The American journal of drug and alcohol abuse
Published: August 24, 2022
Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS.
Journal: Drug and alcohol dependence
Published: March 31, 2021
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
Journal: Journal of systems and integrative neuroscience
Published: February 22, 2021
Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis.
Journal: Frontiers in psychiatry
Published: October 30, 2020
Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.
Journal: Journal of systems and integrative neuroscience
Published: September 16, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
Journal: Current psychopharmacology
Published: May 21, 2020
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency.
Journal: Journal of addiction science
Published: May 21, 2020
Americas' opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs).
Journal: Journal of systems and integrative neuroscience
Published: February 22, 2020
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.
Journal: Current psychopharmacology
Published: January 01, 2020
Last Updated: 09/26/2026